These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11866668)

  • 1. Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent.
    Walenga JM; Jeske WP; Samama MM; Frapaise FX; Bick RL; Fareed J
    Expert Opin Investig Drugs; 2002 Mar; 11(3):397-407. PubMed ID: 11866668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Garcia DA; Baglin TP; Weitz JI; Samama MM
    Chest; 2012 Feb; 141(2 Suppl):e24S-e43S. PubMed ID: 22315264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct antithrombin activation modes for fondaparinux and natural heparins detected using millisecond hydrogen deuterium exchange and collision induced unfolding.
    Listigovers A; Lento C; Wilson DJ
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132868. PubMed ID: 38838881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Xa Activity Test Is Needed but Is Not Enough for Monitoring Fondaparinux Therapy Among Critically Ill Patients.
    Ling L; Liu C; Huang X; Liu S; Liao J; Jia J; Fu Y; Zhou J
    Arch Pathol Lab Med; 2024 Jun; ():. PubMed ID: 38889905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin pentasaccharide.
    Gallus AS; Coghlan DW
    Curr Opin Hematol; 2002 Sep; 9(5):422-9. PubMed ID: 12172461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux (Arixtra): a new anticoagulant.
    Giangrande PL
    Int J Clin Pract; 2002 Oct; 56(8):615-7. PubMed ID: 12425373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.
    Petitou M; Duchaussoy P; Herbert JM; Duc G; El Hajji M; Branellec JF; Donat F; Necciari J; Cariou R; Bouthier J; Garrigou E
    Semin Thromb Hemost; 2002 Aug; 28(4):393-402. PubMed ID: 12244487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors.
    Pollmann H; Richter H; Jürgens H
    Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.
    Douaisi M; Paskaleva EE; Fu L; Grover N; McManaman CL; Varghese S; Brodfuehrer PR; Gibson JM; de Joode I; Xia K; Brier MI; Simmons TJ; Datta P; Zhang F; Onishi A; Hirakane M; Mori D; Linhardt RJ; Dordick JS
    Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315586121. PubMed ID: 38498726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Synthesis of Neutralizable Fondaparinux.
    Zhang L; Liu Y; Xu Z; Hao T; Wang PG; Zhao W; Li T
    JACS Au; 2022 Dec; 2(12):2791-2799. PubMed ID: 36590263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications.
    Heestermans M; Poenou G; Hamzeh-Cognasse H; Cognasse F; Bertoletti L
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When Will Fondaparinux Induce Thrombocytopenia?
    Chen LY; Khan N; Lindenbauer A; Nguyen TH
    Bioconjug Chem; 2022 Aug; 33(8):1574-1583. PubMed ID: 35878320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease.
    Shi D; Sheng A; Chi L
    Front Mol Biosci; 2021; 8():639666. PubMed ID: 33768117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful perioperative management of a patient with erythropoietin-producing uterine myoma.
    Kobayashi M; Akatsu M; Fujita Y; Nishikawa K
    JA Clin Rep; 2018 Jun; 4(1):50. PubMed ID: 32025892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic Enzymes for Thrombolytic Therapy.
    Kumar SS; Sabu A
    Adv Exp Med Biol; 2019; 1148():345-381. PubMed ID: 31482506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Characterization of Glycosaminoglycan Carbohydrates Using Ultraviolet Photodissociation.
    Klein DR; Leach FE; Amster IJ; Brodbelt JS
    Anal Chem; 2019 May; 91(9):6019-6026. PubMed ID: 30932467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots.
    Salta S; Papageorgiou L; Larsen AK; Van Dreden P; Soulier C; Cokkinos DV; Elalamy I; Gerotziafas GT
    Res Pract Thromb Haemost; 2018 Oct; 2(4):696-707. PubMed ID: 30349889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Thrombin, Factor Xa and U46619 Inhibitory Effects of Non-Amidino and Amidino N²-Thiophenecarbonyl- and N²-Tosylanthranilamides.
    Lee SH; Lee W; Nguyen T; Um IS; Bae JS; Ma E
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides.
    Lee SH; Lee W; Bae JS; Ma E
    Molecules; 2016 May; 21(5):. PubMed ID: 27213328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How it all starts: Initiation of the clotting cascade.
    Smith SA; Travers RJ; Morrissey JH
    Crit Rev Biochem Mol Biol; 2015; 50(4):326-36. PubMed ID: 26018600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.